?

Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1501 publications
Global Breast Cancer Monoclonal Antibodies Market Outlook 2020 US$ 1,800.00

... Cancer Monoclonal Antibodies Pipeline: 62 mAb Majority Breast Cancer Monoclonal Antibodies in Preclinical Phase: 17 mAb Marketed Breast Cancer Monoclonal Antibodies: 6 mAb Marketed Breast Cancer Monoclonal Antibodies Clinical Insight Bevacizumab (Avastin) Pertuzumab (Omnitarg, Perjeta) Trastuzumab (Herceptin ...

May, 2015 190 pages
Oxaliplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Oxaliplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Oxaliplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Cisplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Cisplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Cisplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Carmustine Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Carmustine Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Carmustine Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Carboplatin Anti-Cancer Global Market and Forecast Research 2015 US$ 2,600.00

... Note: This report will be updated to last month. Carboplatin Anti-Cancer is an active pharmaceutical ingredient (API) for the pharmaceutical industry. API ( ... , Asia and Europe) Carboplatin Anti-Cancer industry, focusing on the capacity and production volumes, manufacturers, prices, import & export, market forecast and consumers, including ...

May, 2015 65 pages
Ureter Cancer - Pipeline Review, H1 2015 US$ 2,000.00

Ureter Cancer - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Ureter Cancer - Pipeline Review, H1 2015’, provides an overview of the Ureter Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ureter Cancer ...

Apr, 2015 69 pages
Pheochromocytoma - Pipeline Review, H1 2015 US$ 2,000.00

... Pheochromocytoma - Pipeline Review, H1 2015’, provides an overview of the Pheochromocytoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pheochromocytoma, complete with comparative analysis at various stages, therapeutics assessment ...

Apr, 2015 64 pages
Pancreatic Endocrine Tumor - Pipeline Review, H1 2015 US$ 2,000.00

... Tumor - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pancreatic Endocrine Tumor - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Endocrine Tumor’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pancreatic Endocrine Tumor ...

Apr, 2015 59 pages
Vulvar Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Vulvar Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Vulvar Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Uterine Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Uterine Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Uterine Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Insights, 2015 US$ 1,250.00

... Cell Carcinoma) Landscape across the globe The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology ... Cell Carcinoma) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Track your ...

May, 2015 60 pages
Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Insights, 2015 US$ 1,250.00

... Cell Cancer) Landscape across the globe The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology ... Cell Cancer) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Track your ...

May, 2015 60 pages
Thyroid Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Thyroid Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thyroid Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Thymus Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Thymus Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Thymus Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Testicular Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Testicular Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Testicular Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Peritoneal Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Peritoneal Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Peritoneal Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Pediatric Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Pediatric Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Pediatric Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Papillary Thyroid Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Papillary Thyroid Cancer- Pipeline Insights, 2015 Report covers the Papillary Thyroid Cancer pipeline molecules at various ...

May, 2015 60 pages
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) - Pipeline Insights, 2015 US$ 1,250.00

... Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Landscape across the globe The report provides drug profiles which includes product ... Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer) Identify the relationship between the drugs and use it for target finding, drug repurposing, and ...

May, 2015 60 pages
Non Muscle Invasive Bladder Cancer (NMIBC) - Pipeline Insights, 2015 US$ 1,250.00

... a Non Muscle Invasive Bladder Cancer (NMIBC) Landscape across the globe The report provides drug profiles which includes product description, MOA ... Muscle Invasive Bladder Cancer (NMIBC) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine ...

May, 2015 60 pages
Non - Small Cell Lung Carcinoma - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Non-Small Cell Lung Carcinoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Non-Small ... to gain competitive advantage. DelveInsight’s, Non-Small Cell Lung Carcinoma- Pipeline Insights, 2015 Report covers the Non-Small Cell Lung Carcinoma ...

May, 2015 60 pages
Neuroendocrine Carcinoma - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Neuroendocrine Carcinoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Neuroendocrine Carcinoma. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Nasopharyngeal Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Nasopharyngeal Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Nasopharyngeal Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Metastatic Renal Cell Cancer - Pipeline Insights, 2015 US$ 1,250.00

... to gain competitive advantage. DelveInsight’s, Metastatic Renal Cell Cancer- Pipeline Insights, 2015 Report covers the Metastatic Renal Cell Cancer pipeline molecules ...

May, 2015 60 pages
Metastatic Prostate Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Metastatic Prostate Cancer- Pipeline Insights, 2015 Report covers the Metastatic Prostate Cancer pipeline molecules at various ...

May, 2015 60 pages
Metastatic Ovarian Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Metastatic Ovarian Cancer- Pipeline Insights, 2015 Report covers the Metastatic Ovarian Cancer pipeline molecules at various ...

May, 2015 60 pages
Metastatic Lung Cancer - Pipeline Insights, 2015 US$ 1,250.00

... ’s, Metastatic Lung Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Metastatic Lung Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Metastatic Liver Cancer - Pipeline Insights, 2015 US$ 1,250.00

... ’s, Metastatic Liver Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Metastatic Liver Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Insights, 2015 US$ 1,250.00

Summary DelveInsight’s, Head And Neck Cancer Squamous Cell Carcinoma- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Head And Neck Cancer Squamous Cell Carcinoma. The main objective of this report to track competitor pipeline molecules, related research activities, ...

May, 2015 60 pages
Gynecological Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Gynecological Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Gynecological Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Gastrointestinal Tract Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Gastrointestinal Tract Cancer- Pipeline Insights, 2015 Report covers the Gastrointestinal Tract Cancer pipeline molecules at various ...

May, 2015 60 pages
Gallbladder Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Gallbladder Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Gallbladder Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Fallopian Tube Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Fallopian Tube Cancer- Pipeline Insights, 2015 Report covers the Fallopian Tube Cancer pipeline molecules at various ...

May, 2015 60 pages
Esophageal Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Esophageal Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Esophageal Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Epithelial Ovarian Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Epithelial Ovarian Cancer- Pipeline Insights, 2015 Report covers the Epithelial Ovarian Cancer pipeline molecules at various ...

May, 2015 60 pages
Endometrial Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Endometrial Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Endometrial Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Cancer Cachexia - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Cancer Cachexia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cancer Cachexia. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Cancer Anorexia - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Cancer Anorexia- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Cancer Anorexia. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Brain Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Brain Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Brain Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Bone Cancer - Pipeline Insights, 2015 US$ 1,250.00

... DelveInsight’s, Bone Cancer- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Bone Cancer. The main objective of this report to track competitor pipeline molecules ...

May, 2015 60 pages
Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Insights, 2015 US$ 1,250.00

... for Bile Duct Cancer (Cholangiocarcinoma) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine ...

May, 2015 60 pages
Basal Cell Carcinoma (Basal Cell Epithelioma) - Pipeline Insights, 2015 US$ 1,250.00

... Cell Epithelioma) Landscape across the globe The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology ... Cell Epithelioma) Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine. Track your ...

May, 2015 60 pages
Anaplastic Thyroid Cancer - Pipeline Insights, 2015 US$ 1,250.00

... -strategies to gain competitive advantage. DelveInsight’s, Anaplastic Thyroid Cancer- Pipeline Insights, 2015 Report covers the Anaplastic Thyroid Cancer pipeline molecules at various ...

May, 2015 60 pages
Global Prostate Cancer Therapeutics Market to 2020 US$ 1,000.00

... position, while immunotherapy for prostate cancer stands at the last positon in the prostate cancer therapeutics market. Prostate Cancer Drugs Analysis: Zytiga leads the prostate cancer drugs market in 2014. Zytiga is facing ... “Global Prostate Cancer Therapeutics Market to 2020” is a 76 page report with 43 Figures and 4 Tables. This report analyses the Prostate Cancer Therapy Market, Prostate Cancer Drugs Market, driving factors and challenges for prostate cancer market ...

May, 2015 76 pages
Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite New Launches US$ 4,995.00

... business intelligence provider, has released its latest research report, 'Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 - Off-patent Chemo-regimens to Retain Dominance Despite ... for 2013, along with forecasts until 2020 for the Asia-Pacific markets of India, China, Australia and Japan. It also covers disease ...

Jan, 2015 126 pages
Salivary Gland Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Salivary Gland Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Salivary Gland Cancer Global Clinical Trials Review, H1, 2015' provides data on the Salivary Gland Cancer clinical trial ...

Mar, 2015 83 pages
Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015 US$ 2,500.00

Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Nonseminomatous Testicular Cancer Global Clinical Trials Review, H1, 2015' provides data on the Nonseminomatous Testicular Cancer clinical trial ...

Mar, 2015 66 pages
Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015 US$ 2,500.00

... clinical trial report, “Muscle Invasive Bladder Cancer (MIBC) Global Clinical Trials Review, H1, 2015' provides data on the Muscle Invasive Bladder Cancer (MIBC) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Muscle Invasive Bladder Cancer (MIBC ...

Feb, 2015 69 pages
Global Predictive Breast Cancer Gene Testing Industry 2015 Market Research Report US$ 2,850.00

2015 Global Predictive Breast Cancer Gene Testing Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Predictive Breast Cancer Gene Testing industry ... : 1.) basic information; 2.) the Asia Predictive Breast Cancer Gene Testing industry; 3.) the North American Predictive Breast Cancer Gene Testing industry; 4.) the European Predictive Breast Cancer Gene Testing industry; 5.) market entry and ...

Mar, 2015 172 pages
Global In-vitro Colorectal Cancer Screening Tests Industry 2015 Market Research Report US$ 2,850.00

2015 Global In-vitro Colorectal Cancer Screening Tests Industry Report is a professional and in-depth research report on the world's major regional market conditions of the In-vitro Colorectal Cancer Screening Tests industry ... : 1.) basic information; 2.) the Asia In-vitro Colorectal Cancer Screening Tests industry; 3.) the North American In-vitro Colorectal Cancer Screening Tests industry; 4.) the European In-vitro Colorectal Cancer Screening Tests industry; 5.) market entry and ...

Mar, 2015 172 pages
1 2 3 4 5 >
Skip to top